XML 47 R32.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segments (Tables)
12 Months Ended
Dec. 31, 2015
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
 
 
Year ended December 31,
 
 
2015 (1)
 
2014 (2)
 
2013
Gross profit by segment:
 
 
 
 
 
 
Diagnostic Services
 
$
10,439

 
$
10,449

 
$
9,343

Diagnostic Imaging
 
7,470

 
6,191

 
4,773

Consolidated gross profit
 
$
17,909

 
$
16,640

 
$
14,116

 
 
 
 
 
 
 
Income (loss) from operations by segment:
 
 
 
 
 
 
Diagnostic Services
 
$
(506
)
 
$
220

 
$
30

Diagnostic Imaging (3)
 
3,280

 
2,298

 
141

Consolidated income from operations
 
$
2,774

 
$
2,518

 
$
171

 
 
 
 
 
 
 
Depreciation and amortization of tangible and intangible assets by segment:
 
 
 
 
 
 
Diagnostic Services
 
$
2,150

 
$
1,672

 
$
1,436

Diagnostic Imaging
 
291

 
263

 
477

Consolidated depreciation and amortization
 
$
2,441

 
$
1,935

 
$
1,913

 
 
 
 
 
 
 
 
 
December 31,
 
 
 
 
2015 (1)
 
2014 (2)
 
 
Identifiable assets by segment:
 
 
 
 
 
 
Diagnostic Services
 
$
19,478

 
$
18,724

 
 
Diagnostic Imaging
 
44,635

 
23,177

 
 
Consolidated assets
 
$
64,113

 
$
41,901

 
 

(1) On March 5, 2015, we acquired MD Office Solutions (MD Office). The results of MD Office are included in Diagnostic Services since the acquisition date (See Note 3).
(2) On March 13, 2014, we acquired 100% of the membership interest of Telerhythmics, LLC. The results of Telerhythmics are included in Diagnostic Services since the acquisition date (See Note 3).
(3) Included in the Diagnostic Imaging income from operations for the year ended December 31, 2014, are approximately $0.7 million of charges associated with our Diagnostic Imaging and Facilities restructuring initiatives (see Note 11). Included in the Diagnostic Imaging income from operations for the year ended December 31, 2013, are approximately $1.7 million of charges associated with our Diagnostic Imaging restructuring initiative, as well as a gain of approximately $1.6 million associated with the sale of assets and licensing agreement from an uncommercialized surgical imaging system previously in development (See Note 14).